Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.
Adult
Citalopram
/ administration & dosage
Double-Blind Method
Drug Therapy, Combination
Female
Hot Flashes
/ drug therapy
Humans
Menopause
/ drug effects
Middle Aged
Nigella sativa
Phytotherapy
Plant Extracts
/ administration & dosage
Selective Serotonin Reuptake Inhibitors
/ administration & dosage
Treatment Outcome
Vitex
None
MENQOL scores
citalopram
hot flashes
Journal
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
ISSN: 1473-0766
Titre abrégé: Gynecol Endocrinol
Pays: England
ID NLM: 8807913
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
22
8
2018
medline:
14
6
2019
entrez:
22
8
2018
Statut:
ppublish
Résumé
The goal of the current study was to evaluate the efficiency of a phytotherapeutic intervention consisting of a combination of Nigella sativa and Vitex agnus-castus with citalopram in the control of hot flashes in healthy menopausal women. An 8 week, double-blind, randomized, placebo-controlled study was performed among 46 women aged between 40 and 60 years experiencing an average of more than four hot flashes per day recruited during July 2016 to June 2017. Data on severity of vasomotor symptoms were collected at the end of the eighth week. Herbal medication or placebo capsules were administered once daily in morning. At the end of the 8-week treatment period, analyses of covariance demonstrated the superiority of herbal combination with citalopram over placebo and citalopram for three MENQOL domain scores including vasomotor (p < .001), physical (p = .036), psychosocial (p = .001) but no significant differences were observed in terms of sexual function (p = .231). Based on the results, the addition of a combination of N. sativa and V. agnus-castus to the citalopram may be a potential clinical application for improving therapeutic outcomes. Larger randomized, controlled trials are also warranted for further investigations of these symptoms.
Identifiants
pubmed: 30129806
doi: 10.1080/09513590.2018.1499086
doi:
Substances chimiques
Plant Extracts
0
Serotonin Uptake Inhibitors
0
Citalopram
0DHU5B8D6V
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM